A multi center study of cremophor free, polymeric,nanoparticle formulation of pacitaxel (DO/NDR/02) in locally advanced and metastatic breast cancer.

multi center open-label phase III clinicla Trial to evaluate the Safety & Effiacy of Interleukin-2(zenotech) in patients with metastatic renal cell carcinoma.

A Randomized, Double -Blind, Parallel-Group, Multicentric, Phase III Study comparimg Efficacy & Tolerability of Faslodex 500 mg with Faslodex 250 mg in Oestrogen Receptor Positive Advanced Breast Cancer.

A multicentic Study to Evaluate Palonosetron & Ondansetron in chemotherapy induced Nausea and Vomiting.

Efficacy & Safety of XM01 compared to placebo & Epotein beta in patients with solid tumours receiving platinum chemotherapy " A multinational multicentre randomized placebo & active controlled double-blind parallel-group phase III trial.

Efficacy & Safety of XM01 compared to placebo in patients with solid tumours or non-myeloid hematological tumours receiving non-platinum chemotherapy " A multinational multicentre randomized placebo controlled double-blind parallel-group phase III trial.

Efficacy & Safety of XM01 compared to placebo in anaemic patients with low grade non-Hodgkin's lymphoma, chronic lymphocytic leukaemia or multiple myeloma receiving anticancer therapy " A multinational multicentre randomized placebo controlled double-blind parallel-group phase III trial.

A Randomized Phase III Trial of Alimta and Carboplatin versus Etoposide and Carboplatin in Extensive -Stage Small Cell Lung Cancer.

An Open-Label Randomized Phase II Study of Two Different Dosing Regimen of Capecitabine in Combination with Intravenous Docetaxel (Q3W) in patients with Loccaly Advanced or Metastatic Breast Cancer.

A Randomized Phase III Study of Premetrexed in combination with Cisplatin Versus Cisplatin Monotherapy in Patients with Recurrent or Metastatic Head And Neck Cancer.

A Randomized Open-label Multicenter study of single agent Larotaxel (XRP9881) at 75 mg/m2 every 3 weeks compared to continuous administration of 5 FU for the treatment of Advanced Pancreatic Cancer previously treated with gemcitabine reginmen.

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm Study of the Effect of Intravenous AVE0005 (VEGF Trap) Administered Every 2 Weeks in Advanced Ovarian Cancer Patients with Recurrent Symptomatic Malignant Ascites.

Efficacy & Safety of SII r-HuGCSF (SILGRASTIM), r-PEG-HuGCSF (PEG-SILGRASTIM) in correction of Neutropenia in patients with solid Tumour/Lymphomas undergoing Myelosupressive Chemotherapy when compared to Filgrastim.

A Two – Way Crossover Experimental Evaluation of Relative Bioavailabilities of Two Formulations of Temozolomide 250 mg Capsules In Adult Human Male and/Or Female Patients under Fasting Conditions.

An Open-Label, Prospective, Multicentric Study to Assess Safety & Efficacy of BIOMab-EGFR TM in combination with Chemotherapy in the Treatment of patients with Stage IIIB/IV Non Small Cell Lung Cancer.

A Phase III, Randomized, Double-blind Study to Assess the Efficacy and Safety of 10mg ZD4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or Mildly Symptomatic.

A Multicenter, Open-Label, Noncomparative Study of Enzastaurin in Patients with Non-Hodgkin’s Lymphoma.

A Phase II Study to Assess the Safety and Efficacy of the Combination of Carboplatin, Paclitaxel and Bevacizumab ± Combretastatin A4 Phosphate (CA4P) Followed by Bevacizumab ± CA4P in Subjects With Stage IIIB/IV Non-Squamous Cell Histology Non-Small Cell Lung Cancer (NSCLC).